Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. RXRα Blocks Nerve Regeneration after Spinal Cord Injury by Targeting p66shc

RXRα Blocks Nerve Regeneration after Spinal Cord Injury by Targeting p66shc

Oxidative Medicine and Cellular Longevity, 2021 · DOI: https://doi.org/10.1155/2021/8253742 · Published: February 10, 2021

Spinal Cord InjuryAgingNeurology

Simple Explanation

This study investigates the role of retinoid X receptor α (RXRα) and p66shc in nerve regeneration after spinal cord injury. The researchers found that RXRα inhibits nerve regeneration after spinal cord injury. They also discovered that RXRα promotes the expression of p66shc, a protein that regulates cell senescence and oxidative stress. This upregulation of p66shc by RXRα contributes to the inhibition of nerve regeneration. The study suggests that targeting RXRα or p66shc could promote functional recovery after spinal cord injury. Specifically, inhibiting RXRα or p66shc promoted functional recovery after spinal cord injury.

Study Duration
5 weeks
Participants
360 Sprague-Dawley (SD) rats
Evidence Level
Not specified

Key Findings

  • 1
    RXRα agonists inhibit nerve regeneration after spinal cord injury, while RXRα antagonists promote the regeneration of injured neurites and the recovery of motor function in rats.
  • 2
    p66shc expression was upregulated in neurons after spinal cord injury and colocalized with RXRα.
  • 3
    RXRα could bind to the promoter region of p66shc and regulate its expression.

Research Summary

The study found that RXRα inhibits neurite regeneration and functional recovery after spinal cord injury in rats. It demonstrated that RXRα promotes p66shc expression, which impedes neurite regeneration after spinal cord injury. Interfering with RXRα or p66shc promoted functional recovery after spinal cord injury, suggesting potential therapeutic targets.

Practical Implications

Therapeutic Target Identification

Targeting RXRα or p66shc could be a potential therapeutic strategy for promoting nerve regeneration and functional recovery after spinal cord injury.

Drug Development

Development of RXRα antagonists or p66shc inhibitors could lead to new treatments for spinal cord injury.

Understanding SCI Mechanisms

The study enhances understanding of the molecular mechanisms involved in nerve regeneration after spinal cord injury, providing insights for future research.

Study Limitations

  • 1
    The study only focused on RXRα and its downstream target gene p66shc, resulting in certain limitations.
  • 2
    The physiological and pathological functions of p66shc are not limited to the inhibition of neurite regeneration after spinal cord injury.
  • 3
    The specific mechanisms by which p66shc regulates neuronal survival and aging after spinal cord injury need further investigation.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury